Login / Signup

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.

Min-Jie MaoNing XueXue-Ping WangPei-Dong ChiYi-Jun LiuQi HuangShu-Qin DaiWan-Li Liu
Published in: BMC cancer (2018)
Chemokine CCL27 could successfully identify NPC patients within a VCA-IgA-positive population.
Keyphrases
  • epstein barr virus
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • diffuse large b cell lymphoma
  • liver injury
  • drug induced